Articles related to MEDICAL DEVICES

A retrospective analysis of FDA postmarketing reports identified textural changes, pigmentary alteration, and subcutaneous fat loss as the most frequently reported adverse events following radiofrequency microneedling, with most cases occurring on the face and submental area.

The FDA granted 510(k) clearance for a wireless-enabled pressure-modulating goggle system designed to reduce nocturnal intraocular pressure in adults with open-angle glaucoma, with availability expected in Q4 2026.

Pediatric patients who started automated insulin delivery within 6 months of type 1 diabetes diagnosis had a median HbA1c of 7.1% at 24 months versus 9.8% in non-users in a US multicenter retrospective cohort.

Two retina specialists debated whether LIGHTSITE III evidence supports photobiomodulation as treatment for intermediate dry AMD, weighing modest BCVA gains against natural visual acuity variability, study quality concerns, and FDA authorization status.

CPT code 0936T became active in January 2025 for retinal photobiomodulation, with reimbursement determined claim-by-claim and scope-of-practice limits restricting who may perform the procedure.

A boutique cataract surgeon describes a multi-technology, team-aligned workflow associated with a reported 92% premium IOL conversion rate.